drugset / Trial / NCT05914753
Evaluating Xihuang Pill to Improve the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
Evaluate the effectiveness of Xihuang Pill in improving the efficacy of neoadjuvant chemotherapy for breast cancer
Timeline
- Start
- 2023-07-01
- Primary completion
- 2024-06-01
- Completion
- 2025-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Xihuang Pill | Unknown | 3 g | Oral |
| Background | Cyclophosphamide | Other / unclassified | 600 mg/m2 | — |
| Background | Docetaxel | Small molecule | 100 mg/m2 | — |
| Background | Epirubicin | Small molecule | 90 mg/m2 | — |